Literature DB >> 18501303

[Characteristics of encrustation of ureteric stents in patients with urinary stones].

H Bouzidi1, O Traxer, B Doré, J Amiel, H Hadjadj, P Conort, M Daudon.   

Abstract

INTRODUCTION: The goal of this prospective study was to characterize ureteral stents encrustation in stone formers.
MATERIAL AND METHODS: We report the results of a study based on 658 double-J stents (412 men and 246 women) collected from patients with in situ urinary calculi. The mean age was 48.2+/-16.0 years without differences between genders. Ureteral stent encrustation was analysed by infrared spectroscopy. Results are expressed according to the main component.
RESULTS: The mean indwelling time was 73.5+/-73.2 days. The main component in stent encrustations was calcium oxalate (43.8%), essentially the monohydrate form (27.1%), followed by proteins (27.4%), calcium phosphates (16.4% with 8.4% brushite), and uric acid (5.2%). Struvite, detected on 49 stents, was the main component in 2.4% of cases. Significant differences according to gender and age were found: calcium oxalate monohydrate, which represented 24.5% in 20 to 29 years old men class increased to 37.0% in 50 to 59 years class and then decreased in older patients. Calcium oxalate dihydrate increased with age up to 70 years in women while it felt dramatically in man beyond 50 years old. Brushite was more abundant in young men (20.4% in patients aged 20-29 years) and was decreasing beyond this age while it remained in stable proportion for all age classes in women. Increasing prevalence of uric acid encrustations with age was observed, especially in men beyond the age of 70 years. Mineral encrustations increased with the indwelling time, the part of mineral being preponderant after 15 days: 7,3% of the stents had become massively encrusted within 113 days mean period. The comparison between biomaterials showed that silicone stents were significantly less encrusted than polyurethane stents.
CONCLUSION: Stent encrustation constitutes a serious complication of ureteral stent use in stone formers. Lithogenic factors should be considered for the prevention of stent encrustation in these patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18501303     DOI: 10.1016/j.purol.2008.02.004

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  6 in total

1.  Effect of phytate on crystallization on ureteral stents and bacterial attachment: an in vitro study.

Authors:  Paula Calvó; Margalida Mateu-Borras; Antonia Costa-Bauza; Sebastián Albertí; Fèlix Grases
Journal:  Urolithiasis       Date:  2022-09-05       Impact factor: 2.861

Review 2.  Biofabrication and biomaterials for urinary tract reconstruction.

Authors:  Moustafa M Elsawy; Achala de Mel
Journal:  Res Rep Urol       Date:  2017-05-10

3.  Forgotten double-J stent: Experience of a tertiary care center.

Authors:  Vinayak Vajpeyi; Saurabh Chipde; Faiz Ahmed Khan; Sanjay Parashar
Journal:  Urol Ann       Date:  2020-04-14

4.  Silicone-hydrocoated ureteral stents encrustation and biofilm formation after 3-week dwell time: results of a prospective randomized multicenter clinical study.

Authors:  Yazeed Barghouthy; Oliver Wiseman; Eugenio Ventimiglia; Julien Letendre; Jonathan Cloutier; Michel Daudon; Francois Kleinclauss; Steeve Doizi; Mariela Corrales; Olivier Traxer
Journal:  World J Urol       Date:  2021-03-10       Impact factor: 4.226

5.  Forgotten/retained double J ureteric stents: A source of severe morbidity in children.

Authors:  Rajendra B Nerli; Prasad V Magdum; Vikas Sharma; Ajay Kumar Guntaka; Murigendra B Hiremath; Shridhar Ghagane
Journal:  Afr J Paediatr Surg       Date:  2016 Jan-Mar

6.  Does potassium citrate administration change the type and composition of encrusted material on Double-J stent compared to primary stone?

Authors:  Abdolreza Mohammadi; Mohammad Mehdi Rakebi; Maryam Gholamnezhad; Mahin Ahmadi Pishkuhi; Seyed Mohammad Kazem Aghamir
Journal:  Int Urol Nephrol       Date:  2021-05-29       Impact factor: 2.370

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.